Table: begin end state 1 24 cytoplasmic 25 44 transmembrane 45 49 non-cytoplasmic 50 69 transmembrane 70 78 cytoplasmic 79 100 transmembrane 101 116 non-cytoplasmic 117 137 transmembrane 138 144 cytoplasmic 145 169 transmembrane 170 174 non-cytoplasmic 175 194 transmembrane 195 205 cytoplasmic 206 231 transmembrane 232 259 non-cytoplasmic 260 279 transmembrane 280 288 cytoplasmic 289 307 transmembrane 308 321 non-cytoplasmic 322 341 transmembrane 342 349 cytoplasmic 350 371 transmembrane 372 381 non-cytoplasmic 382 403 transmembrane 404 414 cytoplasmic 415 436 transmembrane 437 437 non-cytoplasmic
Input: >GFF3854 MNRTTLSPAVPEGTPNVSLLSQRIFNLPLPLFAIALLVMAAAIVTDTLPTGMIGALLVMM LLGELLGFAGDRLPIIRTYLGGGAIMALFGAASMVYFGWLPAAVADDVASFMKGGGFLDF YIAALITGSILGMDAKVLVKVGSRYALPLLCSVLFAALFAMAVGALLGFSPQDAVVVIAM PIMGGGMGAGAVPMSQIYEQLLGQPASYYISILVPALALGNVFAIIIAGLLNGLGNRYPS LTGNGQMMPGVDVSDKEGPITLPALGIGLVAALSFFIAGQILGKFVPLHPYALMIVLVAL LKVSNLVPESINDAASQWFRFVARNWTFALLFGIGVAFTDLGQVLDAISLTYVLIVFAVV AGAAFGAGLVGRLVGFYPIESAITAGLCMANMGGTGDVAVLSAARRMSLMPFAQISSRLG GALILLISSVVVPLFFT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server